Nautilus Biotechnology Statistics
NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
1.96+0.19 (+10.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 2.04 +4.11%
Nautilus Biotechnology by the numbers
Nautilus Biotechnology has a market capitalization of $249.4 million based on 127.26M shares outstanding. With trailing EPS of $-0.45, Nautilus Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 86.6% above its 50-day average and 5.4% below its 200-day average.
Average daily trading volume is 2.59M shares, or about $5.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NAUT valuation vs. peer median
| Metric | NAUT | Peer median | Difference |
|---|---|---|---|
| Market cap | $249.42M | $87.50M | +185% |
| Avg. volume | 2.59M | 621.84K | +316% |
Peer median across 8 companies: LAB, EYPT, QTRX, SEER, CIRC, RPID, PRPO, HBIO.
Valuation
- Market cap
- $249.42M
- EPS (TTM)
- $-0.45
- Shares outstanding
- 127.26M
Price and trading
- Previous close
- 1.77
- Open
- 1.67
- Day range
- 1.62 – 2.17
- 52-week range
- 0.82 – 4.31
- 52-week change
- +126.33%
- Beta
- —
- Volume
- 12.47M
- Average volume
- 2.59M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 26, 2026
Additional statistics
- Market Cap
- 249.42M
- Forward Pe
- -2.65
- Eps
- -0.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.31
- Week52 Low
- 0.82
- Avg Volume
- 2.59M
- Shares Outstanding
- 127.26M
- Ma50
- 1.05
- Ma200
- 2.07
- Earnings Date
- Oct 26, 2026
- Pct From52w High
- -54.52%
- Pct From52w Low
- 139.02%